icd 9 code for non small cell lung carcinoma
báo cáo hóa học: " Health state utilities for non small cell lung cancer" pot
... <0.0001Progressive -0.1 798 0.021 69 99 -8. 29 <0.0001Response 0.0 193 0.006556 99 2 .94 0.004Stable 0 . . . .Neutropenia -0.0 897 3 0.01543 99 -5.82 <0.0001Febrile Neutropenia -0. 090 02 0.01633 99 -5.51 <0.0001Fatigue ... 0.018 49 99 -3 .97 0.0001Nausea & vomiting -0.04802 0.01618 99 -2 .97 0.0038Diarrhoea -0.0468 0.01553 99 -3.01 0.0033Hair loss -0.04 495 0.01482 99 -3.03 0.0031Rash -0.03248 0.01171 99 -2.77 ... Staging of small cell and non- small cell lung cancer. University of Iowa Virtual Hos-pital; 199 9. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer:...
- 15
- 397
- 0
Báo cáo khoa học: "Phase i study of ‘dose-dense’ pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma" pps
... combination with mitomycin,vindesine, and cisplatin in unresectable stage III non- small cell lung cancer. J Clin Oncol 199 9, 17:2 692 -9. 4. Gandara DR, Chansky K, Albain KS, et al: Long-term survival withconcurrent ... metastatic non- small- cell lung cancer. Ann Oncol 2008, 19: 9 39- 45.doi:10.1186/1748-717X-6-17Cite this article as: Shen et al.: Phase i study of ‘dose-dense’pemetrexed plus carboplatin/radiotherapy for ... randomized trial for stageIIIB or IV non- small cell lung cancer using weekly paclitaxel andcarboplatin followed by maintenance weekly paclitaxel or observation. JClin Oncol 2003, 21: 293 3 -9. 10. Socinski...
- 8
- 295
- 0
Báo cáo khoa học: "Clinical Analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma" pot
... stage small cell lung cancer: analysis of CALGB phase III trial 92 35. Lung Cancer 2008, 62 :92 -98 . 9. Paumier A, Le Pechoux C: Radiotherapy in small- cell lung cancer: whereshould it go? Lung Cancer ... early-stage non- small- cell lung cancer: clinical implications. Radiotherapy &Oncology 2010, 94 :1-11.27. Hiraoka M, Nagata Y: Stereotactic body radiation therapy for early-stage non- small- cell lung ... limited-disease small cell lung cancer: the Japan Clinical OncologyGroup (JCOG) trial 0202. Radiation Oncology 20 09, 4.11. Ball D: Stereotactic radiotherapy for nonsmall cell lung cancer. CurrentOpinion...
- 7
- 364
- 0
báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx
... randomized clinical tri-als. BMJ 199 5, 311: 899 -90 9.3. Bunn PA, Kelly K: New chemotherapeutic agents prolong sur-vival and improve quality of life in non- small cell lung cancer:a review of the literature ... advanced non- small- cell lung cancer: a phase III trial of the European Organiza-tion for Research and Treatment of Cancer Lung CancerGroup – EORTC 0 897 5. J Clin Oncol 2003, 21: 390 9- 391 7.15. ... Vlachon-icolis J: Front-line treatment of advanced non- small- cell lung cancer with docetaxel and gemcitabine: a multicenter phaseII trial. J Clin Oncol 199 9, 17 :91 4 -92 0.23. Rebattu P, Quantin X, Ardiet...
- 8
- 538
- 0
Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx
... CA:Clinical dose-volume histogram analysis for pneumonitis after 3Dtreatment for non- small cell lung cancer (NSCLC). Int J Radiat Oncol BiolPhys 199 9, 45:323-3 29. 25. Kwa SL, Lebesque JV, Theuws JC, ... early-stage non- small- cell lung cancer: clinical implications. Radiother Oncol2010, 94 :1-11.27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic bodyradiotherapy for T1-3N0 non- small cell ... of non- small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-3 89. 16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non- small cell...
- 7
- 297
- 0
Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study" pps
... body radiotherapy for stage I non- small cell lung cancer. Radiother Oncol 2007, 85:4 29- 434. 39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana ... Lagerwaard FJ:Critical review of nonsurgical treatment options for stage I non- small cell lung cancer. Oncologist 2008, 13:3 09- 3 19. 41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, ... non- small cell Lung cancer (ROSEL, ClinicalTrials.gov ID = NCT0068 798 6)has been opened for accrual in August 2008. The study isinitiated by the VU medical centre Amsterdam and theDutch Lung...
- 14
- 308
- 0
Báo cáo khoa học: " Evalution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC)" pptx
... author AbstractBackground: To evaluate the performance of surface-based deformable image registration (DR) for adaptive radiotherapy of non- small cell lung cancer (NSCLC).Methods: Based on 13 patients ... radiotherapy for head-and-neck cancer using anintegrated CT/linear accelerator system. Int J Radiat Oncol BiolPhys 2004, 59: 960 -97 0. 9. Kupelian PA, Ramsey C, Meeks SL, Willough TR, Forbes A, ... parotid glands [8]. Similarfindings were made for non- small- cell lung cancer(NSCLC), where a continuous tumor regression duringradiotherapy was observed [9] .This continuous tumor regression during...
- 13
- 255
- 0
Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf
... sensitivityoverall 92 %delE746-A750 Ab 63% 22.86% 81.1% 99 % 84.6% 79% l858r Ab 100% 75% 97 % 95 .2% 83%IHC specificityoverall 99 %delE746-A750 Ab 100% 92 % 100% 40% 98 .8%L858R Ab 100% 96 .6% 36% 98 .8%Simonetti ... inactivated at 95 °C for 10 min, and the cell extract submitted to PCR. DNAfrom the cell line PC -9 was used as a mutated control for exon 19, and wt control for exons 20 and 21. DNAfrom the H 197 5 cell ... smoker 7 9 Never smoker 45 58HistologyAdenocarcinoma 69 88.4Large -cell carcinoma 5 7.1Squamous cell carcinoma 1 1.4Others 3 4.3Adenocarcinoma subtypeGlandular 36 52.2Solid 20 29 Papillary...
- 8
- 798
- 0
Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot
... 48 190 59 High 158 47 84 58Missing 15 5SCC (n = 191 ) NSLow 89 47 133 64 0.88High 98 51 120 68Missing 4 2SCC, N0 0.15 NSLow 59 47 160 79 High 68 53 1 29 67SCC, N+ 0.034Low 30 50 49 32High ... comprised 191 squamous cell carcinomas(SCCs), 95 adenocarcinomas (ACs), 31 large cell carcino-mas and 18 bronchioloalveolar carcinomas. Due to nodalmetastasis or non- radical surgical margins, 59 (18%)patients ... aftercomplete resection of non- small cell lung carcinoma. Cancer Res 2010,70:8288 -98 . 19. Goldstraw P:The 7th Edition of TNM in Lung Cancer: what now? J ThoracOncol 20 09, 4:671-3.20. Sandler...
- 9
- 662
- 0
Báo cáo toán học: "Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer" ppsx
... re-sponse( 79) 0 ~99 Negative 100~ 199 40% 200~ 299 100 Positive 300~400 58% EGFR protein status is associ-ated with gefitinib treatment response (23) 0 ~99 Negative 100~ 199 39% 200~ 299 200 ... ZD18 39) in non- small- cell lung can-cer. Br J Cancer. 2004; 91 (2): 208-12. 89. Bailey R, Kris M, Wolf M. Gefitinib (Iressa, ZD 18 39) mono-therapy for pretreated advanced non- small cell lung cancer ... advanced non- small- cell lung cancer. Results of a meta-analysis of the literature. Chest. 199 4; 106(3): 861-5. 8. Grilli R, Oxman AD, Julian JA. Chemotherapy for advanced non- small- cell lung cancer:...
- 9
- 203
- 0
Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx
... treatment.IntroductionIn non- small cell lung cancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ofseverity. In fact, while 9% of patients with IIIA-N2NSCLC is candidate for surgery ... Napoli1, Giacomo Carteni’1AbstractBackground: Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is ... considered to be t hefirst-line chemotherapy for non- operable patients withNSCLC. The search for either molecular or genetic mar-kers predictive for docetaxel sensiti vity might constitutefuture...
- 4
- 303
- 0
Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot
... concurrent chemotherapy and radiotherapy for locally advanced non- small- cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 199 8, 42(3):4 69- 78. 29. Claude L, Pérol D, Ginestet C, Falchero ... with mitomycin, vindesine, and cisplatin in unresectable stage III non- small- cell lung cancer. J Clin Oncol 199 9, 17:2 692 -2 699 .3. Komaki R, Seiferheld W, Curran W, Langer C, Lee J, Hauser S, ... Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non- small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 199 9, 45:323-3 29. 15. Tsujino K, Hirota S, Endo M,...
- 8
- 371
- 0
Tìm thêm: hệ việt nam nhật bản và sức hấp dẫn của tiếng nhật tại việt nam xác định các nguyên tắc biên soạn khảo sát chương trình đào tạo gắn với các giáo trình cụ thể xác định thời lượng học về mặt lí thuyết và thực tế điều tra với đối tượng sinh viên học tiếng nhật không chuyên ngữ1 khảo sát các chương trình đào tạo theo những bộ giáo trình tiêu biểu nội dung cụ thể cho từng kĩ năng ở từng cấp độ xác định mức độ đáp ứng về văn hoá và chuyên môn trong ct mở máy động cơ lồng sóc các đặc tính của động cơ điện không đồng bộ hệ số công suất cosp fi p2 đặc tuyến hiệu suất h fi p2 đặc tuyến mômen quay m fi p2 đặc tuyến tốc độ rôto n fi p2 động cơ điện không đồng bộ một pha thông tin liên lạc và các dịch vụ phần 3 giới thiệu nguyên liệu từ bảng 3 1 ta thấy ngoài hai thành phần chủ yếu và chiếm tỷ lệ cao nhất là tinh bột và cacbonhydrat trong hạt gạo tẻ còn chứa đường cellulose hemicellulose chỉ tiêu chất lượng theo chất lượng phẩm chất sản phẩm khô từ gạo của bộ y tế năm 2008 chỉ tiêu chất lượng 9 tr 25